These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20884717)

  • 1. CD30+ lymphoproliferative disorders.
    de Leval L; Gaulard P
    Haematologica; 2010 Oct; 95(10):1627-30. PubMed ID: 20884717
    [No Abstract]   [Full Text] [Related]  

  • 2. Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations.
    Geissinger E; Sadler P; Roth S; Grieb T; Puppe B; Müller N; Reimer P; Vetter-Kauczok CS; Wenzel J; Bonzheim I; Rüdiger T; Müller-Hermelink HK; Rosenwald A
    Haematologica; 2010 Oct; 95(10):1697-704. PubMed ID: 20511667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Facco M; Siviero M; Galvan S; Piazza F; Perin A; Agostini C; Semenzato G
    Blood; 2000 Jul; 96(2):647-54. PubMed ID: 10887130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS
    Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases.
    Segal GH; Kjeldsberg CR; Smith GP; Perkins SL
    Am J Clin Pathol; 1994 Sep; 102(3):292-8. PubMed ID: 8085551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal Involvement by CD30
    Lezama LS; Gratzinger D
    Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
    Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
    Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Of lymphocytes and cutaneous epithelium: keratoacanthomatous hyperplasia in CD30+ lymphoproliferative disorders and CD30+ cells associated with keratoacanthoma.
    Resnik KS; Kutzner H
    Am J Dermatopathol; 2010 May; 32(3):314-315. PubMed ID: 19915450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary cutaneous CD30+ T-cell lymphoproliferation during treatment with fingolimod: Case report and literature review].
    Cesbron E; Monfort JB; Giannesini C; Duriez P; Moguelet P; Senet P; Francès C; Barbaud A; Chasset F
    Ann Dermatol Venereol; 2018; 145(6-7):433-438. PubMed ID: 29673751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS; Hardman DL; Boni R; Dummer R; Kim YH; Smoller BR; Takeshita M; Kikuchi M; Burg G
    Blood; 1996 Sep; 88(5):1765-70. PubMed ID: 8781433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How I treat primary cutaneous CD30
    Shinohara MM; Shustov A
    Blood; 2019 Aug; 134(6):515-524. PubMed ID: 31164331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not bitten by the bug: A CD30
    McKesey J; Vandergriff T; Wickless H
    Am J Hematol; 2018 Feb; 93(2):315-316. PubMed ID: 28699166
    [No Abstract]   [Full Text] [Related]  

  • 15. CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.
    Prieto-Torres L; Rodriguez-Pinilla SM; Onaindia A; Ara M; Requena L; Piris MÁ
    Haematologica; 2019 Feb; 104(2):226-235. PubMed ID: 30630983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Primary Cutaneous CD30
    Chen C; Gu YD; Geskin LJ
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):121-134. PubMed ID: 30497669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis.
    Gelfand JM; Wasik MA; Vittorio C; Rook A; Junkins-Hopkins JM
    J Am Acad Dermatol; 2004 Aug; 51(2):304-8. PubMed ID: 15280854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin.
    Kempf W; Kadin ME; Dvorak AM; Lord CC; Burg G; Letvin NL; Koralnik IJ
    Carcinogenesis; 2003 Feb; 24(2):301-6. PubMed ID: 12584181
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
    Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
    Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
    Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.